BACKGROUND Chronic liver disease, particularly cirrhosis, is associated with worse
outcomes in patients infected with coronavirus disease 2019 (COVID-19). AIM To assess …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) impacted the world
and caused the 2019 coronavirus disease (COVID-19) pandemic. The clinical …

Abstract The coronavirus disease 2019 (COVID-19) pandemic continues to be a global
problem with over 438 million cases reported so far. Although it mostly affects the respiratory …

While respiratory symptoms are prevalent in SARS-CoV-2 infected patients, growing
evidence indicates that COVID-19 affects a wide variety of organs. Coronaviruses affect not …

Introduction: Data are limited on antibody response to the ChAdOx1 nCoV-19 vaccine
(AZD1222; Covishield®) in cirrhosis. We studied the antibody response following two doses …

Background Coronavirus disease-2019 (COVID-19) cases continue to increase globally.
Poor outcomes in patients with COVID-19 and cirrhosis have been reported; predictors of …

Acute-on-chronic liver failure (ACLF) is a condition associated with hepatic and extrahepatic
organ failure with high short-term mortality. 2 The data regarding severe acute respiratory …

BACKGROUND Alcohol-associated cirrhosis (AC) contributes to significant liver-related
mortality in the United States. It is known to cause immune dysfunction and coagulation …

The outbreak of coronavirus disease-2019 (COVID-19) has resulted in a global public health
emergency. Patients with cirrhosis were deemed more susceptible to viral infection because …

Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has had a significant impact on the lives …